Shubhransu Patro
Kalinga Institute of Medical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shubhransu Patro.
ACS Omega | 2018
Suresh K. Verma; Ealisha Jha; Pritam Kumar Panda; Arun Thirumurugan; S. K. S. Parashar; Shubhransu Patro; Mrutyunjay Suar
This study evaluates the impact of industrially prepared TiO2 nanoparticles on the biological system by using an in vitro model of colon cancer cell lines (HCT116). Industrial synthesis of titanium oxide nanoparticles was mimicked on the lab scale by the high-energy ball milling method by milling bulk titanium oxide particles for 5, 10, and 15 h in an ambient environment. The physiochemical characterization by field emission scanning electron microscopy, dynamic light scattering, and UV–visible spectroscopy revealed alteration in the size and surface charge with respect to increase in the milling time. The size was found to be reduced to 82 ± 14, 66 ± 12, and 42 ± 10 nm in 5, 10, and 15 h milled nano TiO2 from 105 ± 12 nm of bulk TiO2, whereas the zeta potential increased along with the milling time in all biological media. Cytotoxicity and genotoxicity assays performed with HCT116 cell lines by MTT assay, oxidative stress, intracellular lipid analysis, apoptosis, and cell cycle estimation depicted cytotoxicity as a consequence of reactive oxygen species quenching and lipid accumulation, inducing significant apoptosis and genotoxic cytotoxicity. In silico analysis depicted the role of Sod1, Sod2, p53, and VLDR proteins–TiO2 hydrogen bond interaction having a key role in determining the cytotoxicity. The particles exhibited significant antibacterial activities against Escherichia coli and Salmonella typhimurium.
Journal of clinical and diagnostic research : JCDR | 2015
Priyadarshi Soumyaranjan Sahu; Shubhransu Patro; Payod Kumar Jena; Santosh Kumar Swain; Bidyut Kumar Das
INTRODUCTION Neurocysticercosis being a potential to human transmitted disease, is the major cause of seizures and a public health problem in tropical countries. Though India is known to be highly endemic, there are many provinces where reports are still unavailable thereby underestimating its actual burden. MATERIALS AND METHODS Anti-Cysticercus IgG antibodies in sera from cases presenting with seizures were screened by ELISA in a preliminary study in Odisha state which is a province in Eastern coastal India that was never explored before. Patients presenting with recent onset of seizures within age group 5 to 50 years, either local residents of Odisha or inhabitants from other parts of the country living for at least one year period in the study area were included. RESULTS The present study showed 43.75% cases with seizures to be confirmed neurocysticercosis (NCC) based on serology and brain imaging. However, statistically no association was established between anti-Cysticercus antibody detection and radio imaging characteristics (location, number of lesions, and stage). CONCLUSION This is the first study in Odisha presenting a series of cases with serological evidence of exposure to the parasite along with imaging characteristics which was consistent with NCC. It is recommended that NCC must be considered for a differential diagnosis in each active epilepsy case irrespective of prior prevalence information in all unexplored provinces in India and other endemic regions; also a compulsory reporting is warranted in order to aid in quantifying its actual burden.
Journal of Forensic and Legal Medicine | 2014
Shreemanta Kumar Dash; Basanta Kumar Behera; Shubhransu Patro
Journal of Indian Academy of Forensic Medicine | 2013
Shreemanta Kumar Dash; Shubhransu Patro; Basanta Kumar Behera
Fems Microbiology Letters | 2016
Jugal Kishore Das; Rajani Kanta Mahapatra; Shubhransu Patro; Chandan Goswami; Mrutyunjay Suar
International Journal of Advances in Medicine | 2015
Shubhransu Patro; Surya Narayan Mishra; Sudhansu Sekhar Panda; Manoranjan Mohapatra
International Journal of Physiology | 2013
Somnath Dash; Jayanti Mishra; Shubhransu Patro; Soumya Mishra; D D Dash
Journal of Evidence Based Medicine and Healthcare | 2018
Surendra Nath Behera; Pankaj Kumar Khora; Debasis Pathi; Sonapuram Keerthi; Sushant Kande; Shubhransu Patro
Asian Journal of Pharmaceutical and Clinical Research | 2018
Magna Manjareeka; Soumya Mishra; Prakash Nayak; Shubhransu Patro; Jayanti Mishra; Suresh Chandra Dash
International Journal of Advances in Medicine | 2017
Surendra Nath Behera; Shubhransu Patro